LONG TERM COSTS ASSESSMENT OF ORAL THERAPIES FOR PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS BASED ON THE EVIDENCE FROM A LARGE REAL-WORLD STUDY APPLICATION TO A PORTUGUESE NATIONAL ACADEMIC HOSPITAL CENTER

被引：0

作者：

Lucio Rodrigues, C. ^{[1
]}

Silverio, N. ^{[2
]}

Tundia, N. ^{[3
]}

机构：

[1] CHULC Hosp Capuchos, Lisbon, Portugal

[2] Merck SA, Lisbon, Portugal

[3] EMD Serono Res & Dev Inst Inc, Billerica, MA USA

来源：

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

EE363

引用

页码：S126 / S126

页数：1